We are updating the design of this site. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Progress Pediatric Study

This study has been completed.
Sponsor:
ClinicalTrials.gov Identifier:
NCT01328288
First Posted: April 4, 2011
Last Update Posted: February 22, 2016
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Collaborators:
Bamrasnaradura Infectious Diseases Institute
Mahidol University
Chiangrai Prachanukroh Hospital
Sanpatong Hospital
Information provided by (Responsible Party):
The HIV Netherlands Australia Thailand Research Collaboration
March 2, 2011
April 4, 2011
February 22, 2016
January 2009
September 2015   (Final data collection date for primary outcome measure)
HIV related adverse events [ Time Frame: 1 year ]
time to HIV related adverse events
Same as current
Complete list of historical versions of study NCT01328288 on ClinicalTrials.gov Archive Site
  • Immunological failure [ Time Frame: 1 year ]
    time to immunological failure
  • virological failure [ Time Frame: 1 year ]
    time to virological failure
  • quality of life [ Time Frame: 1 year ]
    time to change of quality of life
  • depression [ Time Frame: 1 year ]
    when patient develops depression
  • genotypic resistance [ Time Frame: 1 year ]
    time to genotypic resistance
Same as current
Not Provided
Not Provided
 
Progress Pediatric Study
The Thai Pediatric HIV Disease Progression: An Observational Database
The purpose of this study is to study the HIV disease progression in HIV-infected Thai children.
This is a multicenter, observational cohort study. HIV-infected children from 5 institutions are followed to assess HIV disease progression: 1. Bamrasnaradura infectious disease institute,2. Faculty of Medicine Siriraj Hospital, Mahidol University, 3. Chiangrai Prachanukroh Hospital, 4. Sanpatong Hospital and 5. HIV-NAT, Thai Red Cross AIDS Research Center.
Observational
Observational Model: Cohort
Time Perspective: Prospective
Not Provided
Retention:   Samples With DNA
Description:
serum
Probability Sample
long-term follow-up of HIV-infected children from: 1. Bamrasnaradura infectious disease institute, 2. Faculty of Medicine Siriraj Hospital, Mahidol University, 3. Chiangrai Prachanukroh Hospital, Chiang Rai, 4. Sanpatong Hospital, Chiang Mai, and 5. HIV-NAT, Thai Red Cross AIDS Research Center, Bangkok
  • HIV
  • Depression
Drug: standard ART according to the Thai Ministry of Public Health national guidelines
Patients may receive any of the standard regimens. These regimens are recommended in the Thai Ministry of Public Health National guidelines for the treatment of HIV in children. Change of treatment will be according to the treating physicians.
1
long-term follow-up of HIV-infected children
Intervention: Drug: standard ART according to the Thai Ministry of Public Health national guidelines
Bunupuradah T, Sricharoenchai S, Hansudewechakul R, Klinbuayaem V, Teeraananchai S, Wittawatmongkol O, Akarathum N, Prasithsirikul W, Ananworanich J; Pediatric PROGRESS Study Team. Risk of first-line antiretroviral therapy failure in HIV-infected Thai children and adolescents. Pediatr Infect Dis J. 2015 Mar;34(3):e58-62. doi: 10.1097/INF.0000000000000584.

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Completed
840
September 2015
September 2015   (Final data collection date for primary outcome measure)

Inclusion Criteria:

  1. age < 18 years old
  2. Have confirmed HIV infection (ELISA,HIV-DNA PCR,HIV-RNA PCR)
  3. Signed consent form

Exclusion Criteria:

  1. Hospitalization
  2. Emergency case
  3. Incomplete Medical Record
Sexes Eligible for Study: All
up to 18 Years   (Child, Adult)
No
Contact information is only displayed when the study is recruiting subjects
Thailand
 
 
NCT01328288
HIV-NAT 154
No
Not Provided
Not Provided
The HIV Netherlands Australia Thailand Research Collaboration
The HIV Netherlands Australia Thailand Research Collaboration
  • Bamrasnaradura Infectious Diseases Institute
  • Mahidol University
  • Chiangrai Prachanukroh Hospital
  • Sanpatong Hospital
Principal Investigator: Wisit Prasithsirikul, MD Bamrasnaradura infectious disease institute
Principal Investigator: Rawiwan Hansudewechakul, MD Chiangrai Prachanukroh Hospital
Principal Investigator: Wirat Klinbuayam, MD Sanpatong Hospital
Principal Investigator: Jintanat Ananworanich, MD, PhD HIV-NAT, Thai Red Cross - AIDS Research Centre
Principal Investigator: Kulkanya Chokephaibulkit, MD Mahidol University
The HIV Netherlands Australia Thailand Research Collaboration
February 2016